Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 7/2019

01-07-2019 | Mastocytosis | UNM CLINICAL CASE CONFERENCES

A Granular Approach to a Patient with Diarrhea and Flushing

Authors: Anas Gremida, Fazia Mir, Denis McCarthy

Published in: Digestive Diseases and Sciences | Issue 7/2019

Login to get access

Excerpt

A 57-year-old male was initially evaluated for a 3-month history of diarrhea and flushing. His diarrhea was of small volume with a Bristol stool scale 6–7. He had 5–6 bowel movements daily, mostly diurnal with rare nocturnal events, associated with generalized abdominal cramping and nausea, usually occurring 5–10 min after food ingestion, and aggravated by exposure to heat or hot showers. His symptoms were associated with dizziness, nausea, and sense of flushing. The patient denied tenesmus, dyschezia, or hematochezia. Over the 3-month period, the frequency of diarrhea increased, accompanied by intensified abdominal cramps. …
Literature
1.
2.
Krishnaswamy G, Kelley J, Johnson D, Youngberg G, et al. The human mast cell: functions in physiology and disease. Front Biosci. 2001;6:1109–11027.CrossRef
3.
Okayama Y, Kawakami T. Development, migration, and survival of mast cells. Immune Res. 2006;34:97–115.CrossRef
4.
5.
Ashman LK. The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol. 1999;31:1037–1051.CrossRefPubMed
6.
Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005;13:205–220.CrossRefPubMed
7.
Lundequist A, Pejler G. Biological implications of preformed mast cell mediators. Cell Mol Life Sci. 2011;6:965–975.CrossRef
8.
Payne V, Kam PC. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia. 2004;59:695–703.CrossRefPubMed
9.
Lawrence JB, Friedman BS, Travis WD, Chinchilli VM. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. Am J Med. 1991;91:612–624.CrossRefPubMed
10.
Arock M. Mastocytosis, classification, biological diagnosis and therapy. Ann Biol Clin. 2004;62:657–669.
11.
Ertugrul A, Bostanci I, Ozturk Kaymak A, Gurkan A. Pediatric cutaneous mastocytosis and c-KIT mutation screening. Allergy Asthma Proc. 2019;40:123–128.CrossRefPubMed
12.
Lim KH, Tefferi A, Lasho TL, Finke C, et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood. 2009;113:5727–5736.CrossRefPubMed
13.
Parsons ME, Ganellin CR. Histamine and its receptors. Br J Pharmacol. 2006;147:127–135.CrossRef
14.
Togias A. H1-receptors: localization and role in airway physiology and in immune functions. J Allergy Clin Immunol. 2003;112:60–68.CrossRef
15.
Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev. 2008;88:1183–1241.CrossRefPubMed
16.
Thrumond R. The histamine H4 receptor: from orphan to the clinic. Front Pharmacol. 2015;6:65.
17.
18.
Martins C, Teixeira C, Ribeiro S, Trabulo D, et al. Systemic mastocytosis: a rare cause of non-cirrhotic portal hypertension. World J Gastroenterol. 2016;22:6559–6564.CrossRefPubMedPubMedCentral
19.
Schwartz LB. Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. Leuk Res. 2001;25:553–562.CrossRefPubMed
20.
Metcalfe DD. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol. 1991;96:60–65.CrossRef
21.
22.
Ray D, Williams G. Pathophysiological causes and clinical significance of flushing. Br J Hosp Med. 1993;50:594–598.PubMed
23.
Butterfield JH. Systemic mastocytosis: clinical manifestations and differential diagnosis. Immunol Allergy Clin N Am. 2006;26:487–513.CrossRef
24.
Jensen RT. Gastrointestinal abnormalities and involvement in systemic mastocytosis. Hematol Oncol Clin N Am. 2000;14:579–623.CrossRef
25.
Cherner JA, Jensen RT, Dubois A, O’Dorisio TM, et al. Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterology. 1988;95:657–667.CrossRefPubMed
26.
Doyle LA, Sepehr GJ, Hamilton MJ, Akin C, et al. A clinico-pathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients. Am J Surg Pathol. 2014;38:832–843.CrossRefPubMedPubMedCentral
27.
Arguedas MR, Ferrante D. Systemic mastocytosis and giant gastroduodenal ulcer. Gastrointest Endosc. 2001;54:530–533.CrossRefPubMed
28.
Scolapio JS, Wolfe J III, Malavet P, Woodward TA. Endoscopic findings in systemic mastocytosis. Gastrointest Endosc. 1996;44:608–610.CrossRefPubMed
29.
Horny HP, Kaiserling E, Campbell M, Parwaresch MR, et al. Liver findings in generalized mastocytosis. A clinicopathologic study. Cancer. 1989;63:532–538.CrossRefPubMed
30.
Capron JP, Lebrec D, Degott C, Chivrac D, et al. Portal hypertension in systemic mastocytosis. Gastroenterology. 1978;74:595–597.CrossRefPubMed
31.
Horny HP, Metcalfe DD, Bennett JM, Bain BJ, et al. Mastocytosis (mast cell disease). World Health Organization (WHO) classification of tumors. Pathology Genetics. Tumors of haematopoietic and lymphoid tissues. Lyon, France: International agency for research on cancer; 2008:54–63.
32.
Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63:226–232.CrossRefPubMed
33.
Horan RF, Sheffer AL, Austen KF. Cromolyn sodium in the management of systemic mastocytosis. J Allergy Clin Immunol. 1990;85:852–855.CrossRefPubMed
34.
Tolar J, Tope WD, Neglia JP. Leukotriene-receptor inhibition for the treatment of systemic mastocytosis. N Engl J Med. 2004;350:735–736.CrossRefPubMed
35.
Kasamon YL, Kp CW, Subramania S, Ma L. FDA approval summary: midostaurin for the treatment of advanced systemic mastocytosis. Oncologist. 2018;23:1511–1519.CrossRefPubMedPubMedCentral
36.
Vega-Ruiz A, Cortes JE, Sever M, Manshouri T. Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis. Leuk Res. 2009;33:1481–1484.CrossRefPubMedPubMedCentral
37.
Ustun C, Gotlib J, Popat U, Artz A, et al. Consensus opinion on allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis. Biol Blood Marrow Transpl. 2016;22:1348–1356.CrossRef
Metadata
Title
A Granular Approach to a Patient with Diarrhea and Flushing
Authors
Anas Gremida
Fazia Mir
Denis McCarthy
Publication date
01-07-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05673-9

Other articles of this Issue 7/2019

Digestive Diseases and Sciences 7/2019 Go to the issue

Invited Review

Impact of Genes and the Environment on the Pathogenesis and Disease Course of Inflammatory Bowel Disease

Correspondence

CT in Crohn’s Disease Is Beneficial for Patient Care and Should Not Be Feared

Correspondence

Letter to the Editor: “Gastric Per Oral Endoscopic Myotomy (G-POEM) for the Treatment of Refractory Gastroparesis: Early Experience”

Original Article

Predictors of Biliary Strictures After Liver Transplantation Among Recipients of DCD (Donation After Cardiac Death) Grafts

Editorial

Biliary Strictures After Liver Transplantation with Grafts from Donors After Cardiac Death: Narrowing Down the Etiologies

Case Report

Case Report of a Proposed, Novel, Endoscopic “Whitehead Pimple” Sign of Ectopic Esophageal Sebaceous Glands Based on Their Mimicking the Dermatologic and Histopathologic Characteristics of Cutaneous Whitehead Pimples/Closed Comedones

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits